Kevin Tan | Chief Financial Officer |
Carsten Brunn | President and CEO |
Peter Traber | Chief Medical Officer |
Kei Kishimoto | Chief Scientific Officer |
Kristen Kluska | Cantor Fitzgerald |
Raju Prasad | William Blair |
Gil Blum | Needham & Company |
Shu Zhiqiang | BTIG |
Good morning. And welcome to the Selecta Biosciences Third Quarter 2021 Financial Results and Corporate Update Conference Call. Currently, all participants are in a listen-only mode. This call is being webcast live on the Investors & Media section of Selecta’s website at www.selectabio.com and it is being recorded.
For opening remarks, I would like to introduce, Kevin Tan, Chief Financial Officer of Selecta.